The initiation of antibiotic therapy is a common challenge for clinicians caring for hospitalized patients. Many factors influence the choice of whether to start antibiotics, when to start, and which agent or agents to employ. Often the decision to initiate antibiotics and to select appropriate antibiotic agents happens before confirmation of the presence of a treatable infection and before its precise location, severity, and specific infectious cause is identified. Some of the factors to consider include the likelihood of a treatable infection actually being present, the risks of an untreated infection, the odds of predicting the correct pathogen involved, the chances of resolution without antibiotic therapy, and the need to identify the organism definitively. Other antibiotic-related factors include the toxicity profile and the pharmacodynamic parameters of the drug.
This chapter provides guidance for antibiotic selection according to (1) common pediatric clinical syndromes (Table 94-1) and (2) specific bacteria pathogens (Table 94-2). Antibiotic susceptibilities of organisms vary by region, by hospital, and in some cases, units within a hospital. For proper treatment and appropriate use, the clinician must remain cognizant of these ever-changing antibiotic-susceptibility profiles by reviewing the current literature and antibiograms (local and hospital). Importantly, if culture and sensitivity results become available, the clinician should modify antibiotic coverage to the narrowest spectrum that effectively treats the relevant pathogen(s) and adequately targets the site of infection.
ANTIBIOTIC | |||
---|---|---|---|
Bacterial Infection | Common Pathogens | Primary | Alternative |
Bites | Dog/Cat: pasteurella, Streptococcus spp., Staphylococcus spp., Moraxella cattarrhalis, anaerobes | Ampicillin-sulbactam or amoxicillin-clavulanate | Trimethoprim-sulfamethoxazole + clindamycin or ciprofloxacin + clindamycin |
Human: S. viridians, Staphylococcus epi, corynebacterium, eikenella, anaerobes | Same as above | Same as above | |
Brain abscess | Polymicrobial | Vancomycin + metronidazole + cefotaxime/ceftriaxone | Vancomycin + carbapenem |
Cellulitis/erysipelas | S. pyogenes | Cefazolin or cephalexin | Clindamycin or vancomycin (severe infection) |
Deep soft tissue abscess | S. aureus, Streptococcus spp. | Clindamycin | Trimethoprim-sulfamethoxazole or vancomycin (severe infection) or cefazolin (if low MRSA prevalence) |
Periorbital/preseptal | S. aureus, S. pyogenes | Clindamycin | Cephalexin (if low MRSA prevalence) |
Orbital | S. pneumoniae, H. influenzae, M. cattarrhalis, S. aureus, S. pyogenes | Ampicillin-sulbactam +/− vancomycin | Vancomycin + ceftriaxone/cefotaxime or vancomycin and ciprofloxacin† or levofloxacin† or clindamycin + ceftriaxone/cefotaxime |
Cervical adenitis, acute | S. pyogenes, S. aureus, anaerobes | Clindamycin | Ampicillin-sulbactam or amoxicillin-clavulante |
Epiglottitis | S. pyogenes, S. aureus, S. pneumoniae, H. inflenzae (rare) | Cefotaxime/ceftriaxone + vancomycin | Levofloxacin† + clindamycin |
Intra-abdominal infection | Polymicrobial (Escherichia coli and anaerobes) | Ampicillin + gentamicin + metronidazole | Piperacillin-tazobactam or ceftriaxone or cefotaxime + metronidazole or carbapenem if cephalosporin allergy |
Meningitis | Neonates: S. agalactiae, E.coli, L. monocytogenes (rare) | Ampicillin + cefotaxime | Vancomycin + cefotaxime |
Infants: S. pneumoniae, N. meningitidis, late-onset S. agalactiae | Vancomycin + cefotaxime/ ceftriaxone | Vancomycin + levofloxacin† or vancomycin + carbapenem if cephalosporin allergy | |
Children and adolescents: S. pneumoniae, N. meningitidis | Same as above | Same as above | |
Osteomyelitis | S. aureus, S. pyogenes | Clindamycin | Vancomycin or linezolid or oxacillin or cefazolin if low MRSA prevalence |
Otitis media, acute | S. pneumoniae, H. influenzae, M. cattarrhalis | Amoxicillin† | Amoxicillin-clavulanate or ceftriaxone |
Pelvic inflammatory disease | N. gonorrhoeae, C. trachomatis, anaerobes, Enterobacteriaceae, streptococci, S. agalactiae | Doxycycline (PO or IV)§ + cefoxitin | Clindamycin + gentamicin |
Pharyngitis (group A Streptococcus) | Penicillin V (PO) or benzathine penicillin G (IM) (can combine with procaine penicillin 3:1 ratio) | Amoxicillin or cephalexin or clindamycin or azithromycin | |
Pneumonia | |||
Mild/moderate | S. pneumoniae, S. aureus, S. pyogenes | Ampicillin or amoxicillin | Clindamycin or levofloxacin† |
Complicated (empyema or necrotizing) | Same as above | Clindamycin + cefotaxime/ ceftriaxone | Clindamycin + levofloxacin† |
Severe | Same as above | Vancomycin + cefotaxime/ ceftriaxone | Vancomycin + levofloxacin† |
Retropharyngeal/peritonsillar abscess | S. pyogenes, anaerobes, H. influenzae, S. pneumoniae, S. aureus | Ampicillin−sulbactam or amoxicillin-clavulanate | Clindamycin or clindamycin + cefotaxime/ceftriaxone |
Sepsis (immunocompetent) | Vancomycin + cefotaxime/ceftriaxone | Vancomycin + one of the following: ceftazidime, cefepime, ciprofloxacin,† or carbapenem | |
Sepsis (immunocompromised or hospitalized) | Vancomycin + one of the following: ceftazidime, cefepime, ciprofloxacin,† piperacillin/tazobactam, or carbapenem | Linezolid + one of the following: ceftazidime, cefepime, ciprofloxacin,† piperacillin/tazobactam, or carbapenem | |
Septic Arthritis | |||
Typical, acute Hip or shoulder Presumed Lyme Sexually active | S. aureus, S. pneumoniae, S. pyogenes
Same as above and N. gonorrhoeae | Clindamycin Vancomycin Doxycycline§ Cefotaxime/ceftriaxone | Oxacillin or cefazolin Linezolid Ceftriaxone
|
Sinusitis (acute) | S. pneumoniae, H. influenzae, M. cattarrhalis | Amoxicillin‡ | Clindamycin or amoxicillin-clavulanate or levofloxacin† |
Urinary tract infection | |||
Outpatient | E. coli, Klebsiella, Proteus, Enterococcus, S. saprophyticus | Trimethoprim-sulfamethoxazole or cefixime | Cefuroxime or cefprozil or cephalexin |
Inpatient | Ampicillin + gentamicin | Cefotaxime/ceftriaxone or ciprofloxacin† |